AZTR

Azitra Inc · AMEX

Sector Health Technology
Industry Pharmaceuticals: Major
Website azitrainc.com
Employees(FY) 10
ISIN US05479L2034

Performance

-7.75%

-22.95%

-26.79%

-91.39%

-98.3%

YTD

-98.96%

Profile

Azitra, Inc., a pre-clinical biopharmaceutical company, focuses on developing therapies for precision dermatology using engineered proteins and live biotherapeutic products to treat skin diseases. It is developing ATR-12, a genetically modified strain of S. epidermidis for treating Netherton syndrome, a skin disease; ATR-04, a genetically modified strain of S. epidermidis for treating the papulopustular rash experienced by cancer patients undergoing epidermal growth factor receptor inhibitor; and ATR-01, an engineered recombinant human filaggrin protein for treating ichthyosis vulgaris, a skin disease. The company was incorporated in 2014 and is based in Branford, Connecticut.

Advanced Technical Analysis

Technical Analysis of AZTR 2024-11-20

The stock indicators reflect a bearish sentiment overall, with a Moving Average Score of 10 indicating strong downward momentum, an Oscillators Score of 43 suggesting a neutral stance, and a Technical Score of 26 reinforcing the bearish outlook. This combination points to a challenging environment for the stock, with potential for further declines.

Technical Scores and Rating

Moving Average Score

Oscillator Score

Technical Rating

Stock Analysis of AZTR

Stock Rank

Recent News & Updates

2024-11-12 04:05
Azitra, Inc. Announces Q3 2024 Financial Results and Provides Business Updates(Prnewswire)
2024-10-28 21:00
Azitra to Present at BIO-Europe 2024(Yahoo Finance)
2024-10-10 21:00
Azitra to Participate in the 2024 Maxim Healthcare Virtual Summit(Yahoo Finance)
2024-09-23 20:00
Azitra, Inc. Announces Late-Breaking Presentation at the European Academy of Dermatology and Venereology Congress(Yahoo Finance)
2024-09-17 21:00
Azitra Receives Fast Track Designation for ATR-04 for Skin Rash from EGFR Inhibitors(Yahoo Finance)
2024-09-06 04:30
Azitra to Present at the H.C. Wainwright 26th Annual Global Investment Conference(Yahoo Finance)
2024-08-27 20:30
Azitra Announces First Patient Dosed in Phase 1b Trial of ATR-12 for Netherton Syndrome(Yahoo Finance)
2024-08-21 21:00
Azitra Receives Study May Proceed letter from the FDA for IND to Treat Skin Rash from EGFR Inhibitors(Yahoo Finance)
2024-08-20 04:15
Azitra Announces First Patient Screened and Scheduled to Enroll in Phase 1b Trial of ATR-12 for Netherton Syndrome(Yahoo Finance)
2024-08-12 06:23
Azitra, Inc. Announces Q2 2024 Financial Results and Provides Business Updates(Yahoo Finance)
2024-07-25 05:57
CORRECTING and REPLACING Azitra, Inc. Announces Closing of $10.0 Million Public Offering(Yahoo Finance)
2024-07-23 09:20
Azitra, Inc. Announces Pricing of $10.0 Million Public Offering(Yahoo Finance)
2024-07-22 20:00
Azitra, Inc. Strengthens Global Intellectual Property Portfolio with Newly Granted and Allowed Patents(Yahoo Finance)
2024-06-27 04:05
Azitra, Inc. Announces Reverse Stock Split(Yahoo Finance)
2024-05-30 20:00
Azitra, Inc. Announces Presentation at the 2024 BIO International Convention(Yahoo Finance)
2024-05-16 20:00
Azitra, Inc. Announces Positive Preclinical Data from ATR-04 Presented at the Society of Investigative Dermatology Annual Meeting(Yahoo Finance)
2024-05-09 20:00
Azitra, Inc. Announces Positive Preclinical Data of ATR-12 and Clinical Design in Netherton Syndrome Presented at the ASGCT Annual Meeting(Yahoo Finance)
2024-05-09 05:00
Azitra, Inc. Announces Q1 2024 Financial Results and Provides Business Updates(Yahoo Finance)
2024-04-22 04:30
Azitra, Inc. Announces New Preclinical Data to be Presented at the American Society of Gene and Cell Therapy Meeting(Yahoo Finance)
2024-04-18 04:15
Azitra, Inc. to Present New Data at Three Upcoming Scientific Conferences in May 2024(Yahoo Finance)
2024-03-15 04:15
Azitra, Inc. Announces Full Year 2023 Financial Results and Provides Business Updates(Yahoo Finance)
2024-02-16 03:05
Azitra, Inc. Announces Closing of Public Offering(Yahoo Finance)
2024-02-13 09:09
Azitra, Inc. Announces Pricing of Public Offering(Yahoo Finance)
2024-01-15 20:00
Azitra, Inc. Strengthens Intellectual Property Portfolio with Newly Granted Patent in the US(Yahoo Finance)
2024-01-02 20:00
Azitra, Inc. to Present at Biotech Showcase 2024 and the Dermatology Summit 2024, Alongside the J.P. Morgan Annual Healthcare Conference(Yahoo Finance)
2023-11-14 03:30
Azitra, Inc. Announces Third Quarter 2023 Financial Results and Business Updates(Yahoo Finance)
2023-10-15 20:00
Azitra to Present at the ThinkEquity Conference(Yahoo Finance)
2023-08-28 20:00
Azitra to Present at the H.C. Wainwright 25th Annual Global Investment Conference(Yahoo Finance)
2023-08-14 04:05
Azitra, Inc. Announces Second Quarter 2023 Financial Results and Business Updates(Yahoo Finance)
2023-07-19 04:05
Azitra Adds Biotech Leaders Barbara Ryan and John Schroer to Its Board of Directors(Yahoo Finance)

Page 1 of 2

previousnext

Disclaimer: The information provided here and on kavout.com site is for general informational purposes only. It does not constitute investment advice, financial advice, trading advice, or any other sort of advice. Kavout does not recommend that any investment decision be made based on this information. You are solely responsible for your own investment decisions. Please conduct your own research and consult with qualified financial advisors before making any investment. Kavout and its partners are participants in a number of affiliate advertising programs. As an Amazon Associate, Kavout or its partners earn from qualifying purchases from affiliate links. We also participate in other affiliate and advertising programs that provide a means for us to earn advertising fees by advertising and linking to third-party websites.